相似文献
1
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement.
J Infect Dis. 2022 May 16;225(10):1861-1864. doi: 10.1093/infdis/jiab630.
2
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
mBio. 2019 Nov 5;10(6):e02552-19. doi: 10.1128/mBio.02552-19.
3
Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
mBio. 2021 Mar 16;12(2):e00242-21. doi: 10.1128/mBio.00242-21.
4
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Front Immunol. 2019 Feb 27;10:321. doi: 10.3389/fimmu.2019.00321. eCollection 2019.
5
Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.
PLoS Pathog. 2013;9(8):e1003559. doi: 10.1371/journal.ppat.1003559. Epub 2013 Aug 29.
6
Preclinical efficacy of a cell division protein candidate gonococcal vaccine identified by artificial intelligence.
mBio. 2023 Dec 19;14(6):e0250023. doi: 10.1128/mbio.02500-23. Epub 2023 Oct 31.
7
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.
Pathog Dis. 2017 Jun 1;75(4). doi: 10.1093/femspd/ftx049.
8
Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.
PLoS Biol. 2019 Jun 19;17(6):e3000323. doi: 10.1371/journal.pbio.3000323. eCollection 2019 Jun.
9
An optimized Factor H-Fc fusion protein against multidrug-resistant .
Front Immunol. 2022 Aug 30;13:975676. doi: 10.3389/fimmu.2022.975676. eCollection 2022.
10
The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
mBio. 2021 Mar 23;12(2):e03666-20. doi: 10.1128/mBio.03666-20.
引用本文的文献
1
A novel GMMA-based gonococcal vaccine demonstrates functional immune responses in mice.
NPJ Vaccines. 2025 Jul 5;10(1):146. doi: 10.1038/s41541-025-01190-1.
2
In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics.
Vaccines (Basel). 2023 Dec 13;11(12):1846. doi: 10.3390/vaccines11121846.
3
Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved SliC antigen that blocks human lysozyme.
Infect Immun. 2023 Dec 12;91(12):e0024523. doi: 10.1128/iai.00245-23. Epub 2023 Nov 2.
4
Th1-polarized MtrE-based gonococcal vaccines display prophylactic and therapeutic efficacy.
Emerg Microbes Infect. 2023 Dec;12(2):2249124. doi: 10.1080/22221751.2023.2249124.
5
Vertebrate and Invertebrate Animal and New In Vitro Models for Studying Biology.
Pathogens. 2023 May 30;12(6):782. doi: 10.3390/pathogens12060782.
本文引用的文献
1
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species.
Front Immunol. 2020 Dec 10;11:612402. doi: 10.3389/fimmu.2020.612402. eCollection 2020.
2
Requirement of Complement C6 for Intact Innate Immune Responses in Mice.
J Immunol. 2020 Jul 1;205(1):251-260. doi: 10.4049/jimmunol.1900801. Epub 2020 May 22.
3
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
mBio. 2019 Nov 5;10(6):e02552-19. doi: 10.1128/mBio.02552-19.
4
Multi-component meningococcal serogroup B (MenB)-4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency.
Clin Exp Immunol. 2019 Dec;198(3):381-389. doi: 10.1111/cei.13368. Epub 2019 Oct 1.
5
Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.
PLoS Biol. 2019 Jun 19;17(6):e3000323. doi: 10.1371/journal.pbio.3000323. eCollection 2019 Jun.
6
Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
Kidney Int. 2019 Jul;96(1):67-79. doi: 10.1016/j.kint.2019.01.009. Epub 2019 Feb 27.
7
Gonococcal Defenses against Antimicrobial Activities of Neutrophils.
Trends Microbiol. 2018 Dec;26(12):1022-1034. doi: 10.1016/j.tim.2018.07.003. Epub 2018 Aug 13.
8
Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development.
Annu Rev Microbiol. 2017 Sep 8;71:665-686. doi: 10.1146/annurev-micro-090816-093530.
9
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.
Lancet. 2017 Sep 30;390(10102):1603-1610. doi: 10.1016/S0140-6736(17)31449-6. Epub 2017 Jul 10.
10
Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults.
Blood. 2017 Aug 17;130(7):891-899. doi: 10.1182/blood-2017-05-781450. Epub 2017 Jun 19.
Zotero 插件